Literature DB >> 30570746

G protein-coupled estrogen receptor activates cell type-specific signaling pathways in cortical cultures: relevance to the selective loss of astrocytes.

Cláudio Roque1, Julieta Mendes-Oliveira1, Graça Baltazar1,2.   

Abstract

Selective activation of the G protein-coupled estrogen receptor has been proposed to avoid some of the side effects elicited by the activation of classical estrogen receptors α and β. Although its contribution to neuroprotection triggered by estradiol in brain disorders has been explored, the results regarding ischemic stroke are contradictory, and currently, there is no consensus on the role that this receptor may play. The present study aimed to investigate the role of GPER in the ischemic insult. For that, primary cortical cultures exposed to oxygen and glucose deprivation (OGD) were used as a model. Our results demonstrate that neuronal survival was strongly affected by the ischemic insult and concurrent GPER activation with G1 had no further impact. In contrast, OGD had a smaller impact on astrocytes survival but G1, alone or combined with OGD, promoted their apoptosis. This effect was prevented by the GPER antagonist G15. The results also show that ischemia did not change the expression levels of GPER in neurons and astrocytes. In this study, we also demonstrate that selective activation of GPER induced astrocyte apoptosis via the phospholipase C pathway and subsequent intracellular calcium rise, whereas in neurons, this effect was not observed. Taken together, this evidence supports a direct impact of GPER activity on the viability of astrocytes, which seems to be associated with the regulation of different signaling pathways in astrocytes and neurons.
© 2018 International Society for Neurochemistry.

Entities:  

Keywords:  zzm321990GPERzzm321990; Astrocytes; G1; intracellular calcium; ischemia

Mesh:

Substances:

Year:  2019        PMID: 30570746     DOI: 10.1111/jnc.14648

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

Review 1.  Neurodegenerative Disease: Roles for Sex, Hormones, and Oxidative Stress.

Authors:  Nathalie Sumien; J Thomas Cunningham; Delaney L Davis; Rachel Engelland; Oluwadarasimi Fadeyibi; George E Farmer; Steve Mabry; Paapa Mensah-Kane; Oanh T P Trinh; Philip H Vann; E Nicole Wilson; Rebecca L Cunningham
Journal:  Endocrinology       Date:  2021-11-01       Impact factor: 5.051

2.  Proliferation and apoptosis regulation by G protein-coupled estrogen receptor in glioblastoma C6 cells.

Authors:  Coral Estefania Gutiérrez-Almeida; Anne Santerre; Lilia Carolina León-Moreno; Irene Guadalupe Aguilar-García; Rolando Castañeda-Arellano; Sergio Horacio Dueñas-Jiménez; Judith Marcela Dueñas-Jiménez
Journal:  Oncol Lett       Date:  2022-05-18       Impact factor: 3.111

3.  G protein-coupled estrogen receptor 1 (GPER) activation triggers different signaling pathways on neurons and astrocytes.

Authors:  Cláudio Roque; Graça Baltazar
Journal:  Neural Regen Res       Date:  2019-12       Impact factor: 5.135

4.  Differential Effects of the G-Protein-Coupled Estrogen Receptor (GPER) on Rat Embryonic (E18) Hippocampal and Cortical Neurons.

Authors:  Kyle Pemberton; Martina Rosato; Cass Dedert; Chelsea DeLeon; Christopher Arnatt; Fenglian Xu
Journal:  eNeuro       Date:  2022-07-15

Review 5.  Microglial and Astrocytic Function in Physiological and Pathological Conditions: Estrogenic Modulation.

Authors:  Andrea Crespo-Castrillo; Maria-Angeles Arevalo
Journal:  Int J Mol Sci       Date:  2020-05-02       Impact factor: 5.923

Review 6.  Does GPER Really Function as a G Protein-Coupled Estrogen Receptor in vivo?

Authors:  Jing Luo; Dongmin Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-31       Impact factor: 5.555

Review 7.  Does GPER1 Play a Role in Sexual Dimorphism?

Authors:  Janine L Dovey; Nandini Vasudevan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-30       Impact factor: 5.555

8.  G Protein-Coupled Estrogen Receptor Immunoreactivity Fluctuates During the Estrous Cycle and Show Sex Differences in the Amygdala and Dorsal Hippocampus.

Authors:  Ricardo Llorente; Marilena Marraudino; Beatriz Carrillo; Brigitta Bonaldo; Julia Simon-Areces; Pedro Abellanas-Pérez; Marina Rivero-Aguilar; Jose M Fernandez-Garcia; Helena Pinos; Luis M Garcia-Segura; Paloma Collado; Daniela Grassi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-07       Impact factor: 5.555

9.  GPER Agonist G-1 Disrupts Tubulin Dynamics and Potentiates Temozolomide to Impair Glioblastoma Cell Proliferation.

Authors:  Alex Hirtz; Nolwenn Lebourdais; Fabien Rech; Yann Bailly; Athénaïs Vaginay; Malika Smaïl-Tabbone; Hélène Dubois-Pot-Schneider; Hélène Dumond
Journal:  Cells       Date:  2021-12-07       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.